| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.012 | 0.9 |